255 related articles for article (PubMed ID: 18666472)
1. [Secondary prevention after myocardial infarction].
Vacheron A; Bounhoure JP;
Bull Acad Natl Med; 2007 Nov; 191(8):1763-77. PubMed ID: 18666472
[TBL] [Abstract][Full Text] [Related]
2. [Secondary prevention in acute myocardial infarction].
Ferreira R; Ferreira D; Correia MJ; De Sá ME; De Sousa JV; Sousa JV; Tavares MG
Acta Med Port; 2001; 14(2):149-69. PubMed ID: 11475986
[TBL] [Abstract][Full Text] [Related]
3. [Secondary prevention after myocardial infarction].
Czuriga I
Orv Hetil; 2002 Sep; 143(37):2117-28. PubMed ID: 12434627
[TBL] [Abstract][Full Text] [Related]
4. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management.
Deedwania PC; Amsterdam EA; Vagelos RH
Arch Intern Med; 1997 Feb; 157(3):273-80. PubMed ID: 9040293
[TBL] [Abstract][Full Text] [Related]
6. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
Giannuzzi P; Temporelli PL; Marchioli R; Maggioni AP; Balestroni G; Ceci V; Chieffo C; Gattone M; Griffo R; Schweiger C; Tavazzi L; Urbinati S; Valagussa F; Vanuzzo D;
Arch Intern Med; 2008 Nov; 168(20):2194-204. PubMed ID: 19001195
[TBL] [Abstract][Full Text] [Related]
7. [Secondary prevention after myocardial infarction in the aged (author's transl)].
Michel D
Aktuelle Gerontol; 1982 Jul; 12(4):149-54. PubMed ID: 6126140
[TBL] [Abstract][Full Text] [Related]
8. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
[TBL] [Abstract][Full Text] [Related]
9. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
10. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
Wachtel TM; Kucia AM; Greenhill JA
Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiologic factors influencing prognosis after myocardial infarction.
Moss AJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S83-6. PubMed ID: 1725051
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of types of atrial fibrillation in acute coronary syndromes.
Lau DH; Huynh LT; Chew DP; Astley CM; Soman A; Sanders P
Am J Cardiol; 2009 Nov; 104(10):1317-23. PubMed ID: 19892044
[TBL] [Abstract][Full Text] [Related]
13. [Management of the patient with chronic coronary artery disease].
Hagège AA
Rev Prat; 2008 Sep; 58(14):1541-8. PubMed ID: 18839682
[TBL] [Abstract][Full Text] [Related]
14. Ischemia detected on continuous electrocardiography after acute coronary syndrome: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndrome-Thrombolysis In Myocardial Infarction 36) trial.
Scirica BM; Morrow DA; Budaj A; Dalby AJ; Mohanavelu S; Qin J; Aroesty J; Hedgepeth CM; Stone PH; Braunwald E
J Am Coll Cardiol; 2009 Apr; 53(16):1411-21. PubMed ID: 19371824
[TBL] [Abstract][Full Text] [Related]
15. Acute coronary syndromes: management and secondary prevention.
Wenaweser P; Windecker S
Herz; 2008 Feb; 33(1):25-37. PubMed ID: 18273575
[TBL] [Abstract][Full Text] [Related]
16. Benefits of risk factor modification through cardiac rehabilitation.
Borrás IC; Cruz-Jiménez M; Nadal E; Middelhoff A; Rivera A
Bol Asoc Med P R; 2008; 100(4):75-9. PubMed ID: 19400532
[TBL] [Abstract][Full Text] [Related]
17. [Impact of controlling risk factors after myocardial infarction].
Guize L; Iliou MC; Henry P; Lavergne T; Le Heuzey JY
Arch Mal Coeur Vaiss; 1995 Aug; 88 Spec No 3():51-7. PubMed ID: 7503618
[TBL] [Abstract][Full Text] [Related]
18. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.
Toth PP
Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814
[TBL] [Abstract][Full Text] [Related]
19. [Recommendations for secondary prevention after myocardial infarction].
Arntz HR
Z Kardiol; 2004; 93 Suppl 1():I23-5. PubMed ID: 15022004
[TBL] [Abstract][Full Text] [Related]
20. Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population.
Amin AP; Mukhopadhyay E; Nathan S; Napan S; Kelly RF
Transl Res; 2009 Aug; 154(2):78-89. PubMed ID: 19595439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
